文献速递免疫规划

新型α溶血素亚单位疫苗(AT62)对金黄色葡萄球菌皮肤软组织感染的保护效力

Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections.
PubMed 文献 · Vaccine · 2016-11-12

本研究基于α溶血素(Hla)七聚体晶体结构理性设计重组亚单位疫苗AT62,不含固有毒性。小鼠于第0、14、28天接种20μg AT62或牛血清白蛋白(BSA)加Sigma佐剂系统。AT62免疫诱导针对天然Hla的强抗体反应;手术伤口感染模型中AT62组感染组织细菌负荷较BSA组显著降低,被动免疫兔IgG亦减少伤口感染和组织损伤;皮下脓肿形成未被预防;皮肤坏死感染模型中AT62组病变较小、体重丢失减少,但病变内细菌负荷未降低。

要点

  • AT62免疫诱导针对天然Hla的强抗体反应。
  • 手术伤口感染模型中AT62组感染组织细菌负荷较BSA组显著降低。
  • 皮肤坏死感染模型中AT62组病变较小、体重丢失减少,但病变内细菌负荷未降低。

核心结论

  • 数据表明AT62可能成为抗金黄色葡萄球菌多价疫苗的有价值组分。

研究设计与样本

  • 小鼠于第0、14、28天接种20μg AT62或牛血清白蛋白(BSA)混合Sigma佐剂系统®。
  • 评估AT62对手术伤口感染及皮肤软组织感染的保护效力。

主要发现

  • AT62免疫小鼠产生针对天然Hla的强抗体反应。
  • 手术伤口感染模型中,AT62免疫并攻毒USA300金黄色葡萄球菌株的小鼠感染组织细菌负荷较BSA组显著降低。
  • 被动免疫兔IgG至AT62的小鼠伤口感染和组织损伤减少。
  • AT62免疫未预防皮下脓肿形成。
  • 皮肤坏死感染模型中,AT62免疫组病变较对照组小且小鼠体重丢失减少。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Alpha hemolysin (Hla) is a pore-forming toxin produced by most Staphylococcus aureus isolates. Hla is reported to play a key role in the pathogenesis of staphylococcal infections, such as skin and soft tissue infection, pneumonia, and lethal peritonitis. This study makes use of a novel recombinant subunit vaccine candidate (AT62) that was rationally designed based on the Hla heptameric crystal structure. AT62 comprises a critical structural domain at the N terminus of Hla, and it has no inherent toxic properties. We evaluated the efficacy of AT62 in protection against surgical wound infection and skin and soft tissue infection. Mice were vaccinated on days 0, 14, and 28 with 20μg AT62 or bovine serum albumin (BSA) mixed with Sigma adjuvant system®. Mice immunized with AT62 produced a robust antibody response against native Hla. In the surgical wound infection model, mice immunized with AT62 and challenged with a USA300 S. aureus strain showed a significantly reduced bacterial burden in the infected tissue compared to animals given BSA. Similarly, mice passively immunized with rabbit IgG to AT62 showed reduced wound infection and tissue damage. Subcutaneous abscess formation was not prevented by immunization with AT62. However, in a skin necrosis infection model, immunization with the AT62 vaccine resulted in smaller lesions and reduced mouse weight loss compared to controls. Although AT62 immunization reduced tissue necrosis, it did not reduce the bacterial burdens in the lesions compared to controls. Our data indicate that AT62 may be a valuable component of a multivalent vaccine against S. aureus.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Adhikari RP, Thompson CD, Aman MJ, et al. Protective efficacy of a novel alpha hemolysin subunit vaccine (AT62) against Staphylococcus aureus skin and soft tissue infections. Vaccine. 2016. PMID: 27847174. doi:10.1016/j.vaccine.2016.09.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。